Donald Notman, Chief Financial Officer at OCULAR THERAPEUTIX, INC (OCUL), sold 6,433 shares at $4.95 ($32K) on 2024-01-31, disclosed to the SEC on 2024-02-02.
Open-market sale of $32k OCUL by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| OCUL | SELL | 2026-02-04 | $101K | — | Filing → |
| OCUL | SELL | 2025-09-04 | $13K | — | Filing → |
| OCUL | SELL | 2025-02-04 | $223K | — | Filing → |